
Dupixent Cancer Lawsuit: Update, Eligibility & Compensation
Dupixent Cancer Lawsuit Key Updates (August, 2026) Current Litigation Status Individual Dupixent Cancer Lawsuit: Plaintiffs across the U.S. are currently filing individual product liability and wrongful death claims. MDL Motion Pending: In February 2026, a motion was filed to transfer and consolidate related federal cases into a Multidistrict Litigation (MDL) in the Northern District of Georgia. No Settlements or Verdicts: There have been no jury


